Accelerating innovation through science and technology

“Innovation means finding new treatments for patients,” according to Lan Chen, a global leader in oncology drug development at Johnson & Johnson Innovative Medicine in Japan.

With a unique background bringing together scientific expertise (Ph.D, biochemistry), MBA business training and a commitment to putting patients first, Market Access leader Tom Kamenski knows that his field is a tapestry woven of many different threads.

Katie shares her dedication to cancer research and how J&J’s innovative approach drives breakthroughs in patient care.

Learn how Victor Villalobos and the team at Johnson & Johnson Innovative Medicine are reimagining what’s possible in healthcare, delivering transformative medicines—and accelerating a healthier future for all.

By applying rigorous science with compassion, physician Joshua Bauml and his team at Johnson & Johnson Innovative Medicine are advancing on a singular goal: eradicating lung cancer for good.

Learn how PharmD-MPH Alex Marshall is applying his passion—together with J&J’s innovative approach—to transform cancer care and make a global impact.

Want to use your business expertise or finance acumen to hep drive better healthcare outcomes for people everywhere? Ekta Butala shares how she's doing it on the oncology team at J&J.

We’re broadening the scope of data science at Johnson & Johnson, extending its range of applications in bold new ways to bring innovation to life.

The so-called "pitfalls of data science" can also teach valuable lessons—in fact, they're helping us change the future of health. Find out what's so unique about our approach.

Jorge Alvarez, M.D., went from working as a front-line healthcare professional to shaping healthcare systems at scale. Find out why the trained physician thinks of Market Access as “an unlimited opportunity for impact”—and how you can join him on our team as well.

At the intersection of biology and technology, Johnson & Johnson Innovative Medicine is transforming the patient experience, breaking down barriers to access and addressing the leading causes of mortality today. Maren Gaudig, Senior Global Compound Market Access Lead, Cell Therapy, explains.

Learn how data scientist Kristopher Standish is applying his unique skill set, collaborating and innovating to improve the lives of patients.